Abstract
Refractory edema is a clinical condition which recognises different etiologies and is characterized by decreased or absent diuretic response before the therapeutic goal is reached. Several pharmacokinetic and pharmacodynamic strategies are used in this setting, and further research is needed in order to optimize drug effectiveness.
MeSH terms
-
Drinking
-
Drug Administration Routes
-
Edema / drug therapy*
-
Edema / etiology
-
Furosemide / administration & dosage
-
Furosemide / pharmacology
-
Furosemide / therapeutic use
-
Heart Failure / complications
-
Heart Failure / physiopathology
-
Humans
-
Hydrostatic Pressure
-
Liver Cirrhosis / complications
-
Liver Cirrhosis / physiopathology
-
Loop of Henle / drug effects
-
Loop of Henle / physiopathology
-
Natriuresis / drug effects
-
Nephrotic Syndrome / complications
-
Nephrotic Syndrome / physiopathology
-
Sodium Potassium Chloride Symporter Inhibitors / administration & dosage
-
Sodium Potassium Chloride Symporter Inhibitors / pharmacology
-
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use*
-
Water-Electrolyte Imbalance / etiology
-
Water-Electrolyte Imbalance / prevention & control
Substances
-
Sodium Potassium Chloride Symporter Inhibitors
-
Furosemide